90 filings
8-K
NNMX
NANOMIX Corp
24 Nov 23
Departure of Directors or Certain Officers
4:20pm
8-K
NNMX
NANOMIX Corp
10 Mar 23
Regulation FD Disclosure
4:04pm
8-K
NNMX
NANOMIX Corp
25 Jan 23
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer
4:43pm
8-K
NNMX
NANOMIX Corp
10 Nov 22
Unregistered Sales of Equity Securities
8:35am
8-K
NNMX
NANOMIX Corp
9 Sep 22
Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors
4:23pm
8-K
n9xpr
29 Jul 22
Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors
3:57pm
8-K
hu0rxe
10 May 22
Nanomix Appoints Vidur Sahney as Chief Operating Officer
4:06pm
8-K
twlgzt7v0 xr
24 Mar 22
Entry into a Material Definitive Agreement
9:13am
8-K
32hg6r
2 Mar 22
Nanomix Completes 1-for-173 Reverse Stock Split
5:27pm
8-K
7tyj4sxafg 7t0n1
1 Mar 22
Entry into a Material Definitive Agreement
8:58am
8-K
ul8967xqwxpba3gd
17 Nov 21
Other Events
12:00am
8-K
s78 xvkgdg3
5 Nov 21
Regulation FD Disclosure
5:06pm
8-K/A
pup6dmk260qyi7leity
5 Nov 21
Other Events
4:47pm
8-K
xa593y ae7
10 Sep 21
Amendments to Articles of Incorporation or Bylaws
2:05pm
8-K/A
1qf060z9cqt
27 Aug 21
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
8-K
r7tis6u2f98y 21cd
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
427ym5awhjtmiualyfpd
10 Jun 21
Entry into a Material Definitive Agreement
5:00pm
8-K
0cpmnc9g
12 May 21
Entry into a Material Definitive Agreement
5:08pm
8-K
t6lvfj
2 Feb 21
Entry into a Material Definitive Agreement
5:00pm
8-K
bm2saerpshm4kfh sgc
15 May 20
Other Events
4:54pm